Showing results (671-680 of 2,715) with videos related to
Sort By:
Pageof 272
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 11, 2020
Meta-Analysis of Secondary Prevention of Cryptogenic StrokeBabikir Kheiri, Timothy F Simpson, Mohammed Osman, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 6, 2022
Left Atrial Appendage Occlusion in Hereditary Haemorrhagic Telangiectasia Patients (Rendu Osler Syndrome) With Non-Valvular Atrial Fibrillation: Prevention of Cardioembolic Events While Avoiding the Long-Term Risks of Oral AnticoagulationPedro Luis Cepas-Guillen, José Ramón López-Mínguez, Jean Carlos Núñez García, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 21, 2022
Invasive Management and In-Hospital Outcomes of Myocardial Infarction Patients in United States Safety-Net HospitalsHussein Bashar, Aditya Bharadwaj, Andrija Matetić, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 22, 2022
Sex Differences in Clinical Profile and Outcome After Percutaneous Coronary Intervention for Chronic Total OcclusionAhmad Shoaib, Vinoda Sharma, James C Spratt, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 21, 2022
The Effect of Ivermectin on Cases of COVID-19Frank H Annie, James Campbell, Lauren Searls, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 23, 2022
Colchicine and Quality of Life in Patients With Acute Coronary Syndromes: Results From the COPS Randomized TrialLuke P Dawson, Stephen Quinn, David Tong, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 23, 2022
Rationale and Design of the Project to Look for Early Discharge in Patients Undergoing TAVR With ACURATE (POLESTAR Trial)Joris F Ooms, Kristoff Cornelis, Pieter R Stella, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 23, 2022
Case Report: Use of Percutaneous Coronary Revascularization to Temporarily Stabilize a Patient With Streptococcus Viridans Bioprosthetic Aortic Valve Endocarditis Resulting in Non-Embolic Left Main Coronary Artery ObstructionRonald P CaputoCardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2022
Secundum Atrial Septal Defects Transcatheter Closure: An Updated ReappraisalGianluca Rigatelli, Filippo Gianese, Marco ZuinCardiovascular Revascularization Medicine : Including Molecular Interventions|June 11, 2022
Transcatheter Aortic Bioprosthesis Durability: A Single-Center ExperienceFrancesco Moroni, Francesca Ziviello, Francesco Federico, et al.Pageof 272